[1]马 蓉,张新爱,杨 洋,等.腺苷酸环化酶相关蛋白2、纤维连接蛋白1表达与胃癌病理类型及预后关系探讨[J].陕西医学杂志,2021,50(2):241-244.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.029]
　MA Rong,ZHANG Xin'ai,YANG Yang,et al.Correlation between pathological types,prognosis of gastric cancer and the expression of CAP2 and FN1[J].,2021,50(2):241-244.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.029]
点击复制

腺苷酸环化酶相关蛋白2、纤维连接蛋白1表达与胃癌病理类型及预后关系探讨
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
50
期数:
2021年2期
页码:
241-244
栏目:
临床病理
出版日期:
2021-02-05

文章信息/Info

Title:
Correlation between pathological types,prognosis of gastric cancer and the expression of CAP2 and FN1
作者:
马 蓉; 张新爱; 杨 洋; 吴红梅
(宝鸡市人民医院病理科,陕西 宝鸡721000)
Author(s):
MA Rong; ZHANG Xin'ai; YANG Yang; WU Hongmei
(Department of Pathology,Baoji People's Hospital,Baoji 721000,China)
关键词:
胃癌;  病理类型;  腺苷酸环化酶相关蛋白2;  纤维连接蛋白1;  预后
Keywords:
Gastric cancer;  Pathological type;  Adenylate cyclase-associated protein 2;  Fibronectin 1;  Prognosis
分类号:
R 735.2
DOI:
DOI:10.3969/j.issn.1000-7377.2021.02.029
文献标志码:
A
摘要:
目的:探究腺苷酸环化酶相关蛋白2(CAP2)、纤维连接蛋白1(FN1)的表达与胃癌病理类型及预后相关性。方法:回顾性分析行胃癌根治术手术切除患者118例,采用免疫组化法评估CAP2、FN1在胃癌组织及癌旁组织中表达的差异,探究其表达与患者病理类型及预后的关系。结果:CAP2、FN1在胃癌组织中呈高表达(P<0.05),在癌旁组织中呈低表达(P<0.05); CAP2、FN1表达与组织分化、淋巴结转移、浸润深度有关(均P<0.05),与性别、年龄、癌细胞类型、肿瘤部位、肿瘤大小无关(均P>0.05); 随访3年,总生存率为60.17%; CAP2低表达组的3年生存率为76.47%,高于CAP2高表达组的47.76%(P<0.05); FN1低表达组的3年生存率为77.55%,高于FN1高表达组的47.83%(P<0.05)。结论:CAP2与FN1在胃癌组织中表达水平均较高,其表达量与组织分化、浸润深度、淋巴结转移相关,参与肿瘤的进展,较高水平的CAP2与FN1表达会影响患者的生存情况,CAP2、FN1可作为肿瘤治疗的药物靶点。
Abstract:
Objective:To explore the correlation between pathological types,prognosis of gastric cancer and the expression of adenylate cyclase-associated protein 2(CAP2)and fibronectin 1(FN1).Methods:A retrospective analysis was performed on the 118 patients.The differences of CAP2 and FN1 in gastric cancer tissues and para-carcinoma tissues were evaluated by immunohistochemistry.The relationship between their expression levels and pathological types,prognosis was explored.Results:CAP2 and FN1 were highly expressed in gastric cancer tissues(P<0.05),while lowly expressed in para-carcinoma tissues(P<0.05).The expression of CAP2 and FN1 was related to tissue differentiation,lymph node metastasis and invasion depth(all P<0.05),while not related to gender,age,types of cancer cells,tumor site,and tumor size(all P>0.05).After 3-year follow-up,the overall survival rate was 60.17%.The 3-year survival rate in CAP2 low-expression group was higher than that in CAP2 high-expression group(76.47% vs.47.76%)(P<0.05).The 3-year survival rate in FN1 low-expression group was higher than that in FN1 high-expression group(77.55% vs.47.83%)(P<0.05).Conclusion:The expression levels of CAP2 and FN1 are higher in gastric cancer tissues.Their expression levels are related to tissue differentiation,invasion depth and lymph node metastasis,which are involved in tumor progression.High levels of CAP2 and FN1 will affect survival of patients.CAP2 and FN1 can be applied as drug targets for tumor treatment.

参考文献/References:

[1] Wei SS,Hong QX,Cheng YL,et al.Endothelin-A receptor in gastric cancer and enhanced antitumor activity of trastuzumab in combination with the endothelin-A receptor antagonist ZD4054[J].Ann NY Acad Sci,2019,1448(1):30-41.
[2] Mu A,Tak SF,Arminja NK,et al.A complex containing lysine-acetylated actin inhibits the formin INF2[J].Nat cell Biol,2019,21(5):592-602.
[3] Lara JK,Fidan D,Teresa DC,et al.CAP2 deficiency delays myofibril actin cytoskeleton differentiation and disturbs skeletal muscle architecture and function[J].Proc Natl Acad Sci USA,2019,116(17):8397-8402.
[4] 姚 远,李胜昔.FN1在胃癌组织和细胞中的表达及意义[J].现代肿瘤医学,2019,27(16):2831-2835.
[5] Sung CO,Park CK,Kim SH.Classification of epithelial-mesenchymal transition phenotypes in esophageal squamous cell carcinoma is strongly associated with patient prognosis[J].Mod Pathol,2011,24(8):1060-1068.
[6] Sun X,Zhang X,Zhai H,et al.A circular RNA derived from COL6A3 functions as a ceRNA in gastric cancer development[J].Biochem Biophys Res Commun,2019,515(1):16-23.
[7] Masugi Y,Tanese K,Emoto K,et al.Overexpression of adenylate cyclase-associated protein 2 is a novel prognostic marker in malignant melanoma[J].Pathol Int,2016,65(12):627-634.
[8] Liam A,Aviva L,Sharon E,et al.CAP2 mutation leads to impaired actin dynamics and associates with supraventricular tachycardia and dilated cardiomyopathy[J].J Med Genet,2019,56(4):228-235.
[9] 孙梦雨,邱洁萍,吴之涵,等.胃癌枢纽基因的筛选和预后分析[J].中国普通外科杂志,2019,28(4):57-64.
[10] Shin M,Leeuwen J,Boone C,et al.Yeast Aim21/Tda2 both regulates free actin by reducing barbed end assembly and forms a complex with Cap1/Cap2 to balance actin assembly between patches and cables[J].Mol Biol Cell,2018,29(8):923-936.
[11] 杨琰茗,杨雅清,宋 杲.腺苷酸环化酶的研究进展[J].临床与病理杂志,2019,39(2):390-394.
[12] 葛思堂,王 姗,项武军,等.腺苷酸环化酶相关蛋白2在胃癌组织中高表达并与肿瘤进展密切相关[J].南方医科大学学报,2019,39(9):1052-1058.
[13] Li L,Luo QF,Hui JW,et al.CAP2 is a valuable biomarker for diagnosis and prognostic in patients with gastric cancer[J].Pathol Oncol Res,2020,26(3):273-279.
[14] 徐茜楠,张 颖,邢国兰.纤维连接蛋白肾病FN1基因突变家系报告及致病机制分析[J].中华肾脏病杂志,2018,34(6):458-461.
[15] 许晓芳,曾德华,郑智勇,等.纤维连接蛋白肾小球病1例[J].临床与实验病理学杂志,2018,35(5):587-588.
[16] Kai YJ,Hong ML,Dong YX,et al.Differentially expressed genes ASPN,COL1A1,FN1,VCAN and MUC5AC are potential prognostic biomarkers for gastric cancer[J].Oncol Lett,2019,17(3):3191-3202.
[17] 姚 远,李胜昔.胃癌相关基因COL1A2、FN1、COL6A3预后分析[J].解剖科学进展,2019,25(5):525-527.
[18] Sun Y,Zhao C,Ye Y,et al.High expression of fibronectin 1 indicates poor prognosis in gastric cancer[J].Oncology Letters,2020,19(1):93-102.
[19] 孙 阳,赵春临.纤维连接蛋白1在胃癌中的表达及临床意义[J].医学研究生学报,2019,32(6):629-633.

相似文献/References:

[1]侯洁心 ,郭萍△.免疫组化标志物Her2和肿瘤标志物在胃癌诊断中的价值分析*[J].陕西医学杂志,2019,(1):121.
　HOU Jiexin,GUO Ping..The value of immunohistochemical marker Her2 andtumor markers in the diagnosis of gastric cancer[J].,2019,(2):121.
[2]唐亚荣.循环热灌注化疗联合替吉奥及热疗治疗老年胃癌癌性腹水临床研究*[J].陕西医学杂志,2019,(4):435.
　TANG Yarong..Clinical effect analysis of combined therapy with tiago and hyperthermia in the treatment of malignant ascites in elderly patients with gastric cancer[J].,2019,(2):435.
[3]刘国庆,闫 龙△,高 任.1.5T磁共振扩散加权成像在胃癌淋巴结转移诊断中的应用价值*[J].陕西医学杂志,2019,(4):456.
　LIU Guoqing,YAN Long,GAO Ren..1.5T magnetic resonance diffusion weighted imaging in the diagnosis of lymph node metastasis of gastric cancer[J].,2019,(2):456.
[4]胡乃军,王海龙.胃腺癌组织中MMP11、MMP12和VEGFD的表达及临床意义[J].陕西医学杂志,2019,(5):554.
[5]米志宽,赵菊梅.抑癌基因甲基化与胃癌关系研究进展*[J].陕西医学杂志,2019,(5):679.
　MI Zhikuan,ZHAO Jumei..Research progress of relationships between tumor suppressor gene methylation and gastric cancer[J].,2019,(2):679.
[6]石颖鹏,王敏娟,李程亮.肠化生相关分子与胃癌的发生和进展研究概况[J].陕西医学杂志,2019,(7):958.
　SHI Yingpeng,WANG Minjuan,LI Chengliang,et al.Intestinal metaplasia-related molecules and the occurrence and progress of gastric cancer[J].,2019,(2):958.
[7]郭小艳,于桂萍.抗幽门螺杆菌疗法联合新辅助化疗对胃癌术后疗效及患者血清VEGF、bFGF的影响[J].陕西医学杂志,2019,(8):1010.
　GUO Xiaoyan,YU Guiping..Effect of anti-Helicobacter pylori therapy combined with neoadjuvant chemotherapy on serum VEGF and bFGF in postoperative patients with gastric cancer[J].,2019,(2):1010.
[8]柯东平,毛俊倩,郭甲民,等.SCNN1B与胃癌细胞上皮间质转化相关性实验研究*[J].陕西医学杂志,2019,(9):1115.
　KE Dongping,MAO Junqian,GUO Jiamin,et al.Research on the correlation between SCNN1B and〖JZ〗 epithelialmesenchymal transformation in gastric cancer cells[J].,2019,(2):1115.
[9]王小林,马任远,张 哲.腹腔镜手术治疗老年进展期胃癌50例临床疗效分析[J].陕西医学杂志,2019,(10):1360.
[10]刘维帅,郭晓宁,杨 洋,等.胃癌病理类型及临床预后与血清miR-133a和DKK-1相关性分析[J].陕西医学杂志,2020,49(6):751.[doi:DOI:10.3969/j.issn.10007377.2020.06.028]
　LIU Weishuai,GUO Xiaoning,YANG Yang,et al.Correlation of pathological types and clinical prognosis of gastric cancer with serum miR-133a and DKK-1[J].,2020,49(2):751.[doi:DOI:10.3969/j.issn.10007377.2020.06.028]

更新日期/Last Update: 2021-01-28